Mbx Biosciences, INC. (MBX) — SC 13D Filings
All SC 13D filings from Mbx Biosciences, INC.. Browse 4 Activist Stake Filing reports with AI-powered summaries and risk analysis.
SC 13D Filings (4)
-
Frazier Life Sciences Takes 10.4% Stake in MBX Biosciences
— Sep 23, 2024 Risk: medium
On September 23, 2024, Frazier Life Sciences Public Fund, L.P. and its affiliates, including Albert Cha and Daniel Estes, reported a beneficial ownership of 1,7 -
Norwest Venture Partners Discloses Stake in MBX Biosciences
— Sep 23, 2024 Risk: medium
On September 23, 2024, Norwest Venture Partners XVI, LP, along with Genesis VC Partners XVI, LLC, NVP Associates, LLC, Jeffrey Crowe, and Tiba Aynechi, filed a -
NEA 17 Files SC 13D for MBX Biosciences
— Sep 23, 2024 Risk: medium
New Enterprise Associates 17, L.P. (NEA 17) and its group members, including individuals like Ali Behbahani and Scott D. Sandell, have filed a Schedule 13D on S -
OrbiMed Adjusts Stake in MBX Biosciences
— Sep 23, 2024 Risk: medium
On September 16, 2024, OrbiMed Advisors LLC, along with its affiliates OrbiMed Capital GP VII LLC and OrbiMed Genesis GP LLC, reported a change in beneficial ow
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX